Problems associated with randomized controlled clinical trials in breast cancer

Area of Science:

• Oncology
• Clinical Research Methodology

Background:

• The TNM classification system for breast cancer has limitations in predicting tumor behavior.
• Current methods fail to adequately measure key prognostic factors like metastasis presence, size, and growth rate.

Purpose of the Study:

• To question the suitability of randomized controlled trials (RCTs) for evaluating adjuvant breast cancer therapy.
• To highlight the limitations of current clinical research methods in accurately assessing treatment efficacy.

Main Methods:

• Critically analyzed the application of TNM classification in breast cancer research.
• Evaluated the biological limitations of detecting early-stage metastases.
• Proposed an alternative research approach based on individual tumor response.

Main Results:

• TNM classification shows poor correlation with actual tumor behavior.
• Metastases are often undetectable at early stages, complicating trial design.
• Intrinsic variability in tumor growth and metastasis timing renders standard trial endpoints unreliable.

Conclusions:

• RCTs are a suboptimal tool for investigating adjuvant breast cancer treatments due to inherent biological and methodological limitations.
• An alternative approach focusing on individual tumor response to primary medical treatment is recommended for more accurate research.